Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
... a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years ... Read More
-
The World Market for HbA1c Tests
... being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the ... Read More
-
Global Type 1 Diabetes Market and Competitive Landscape – 2017
... market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Type 1 Diabetes market size and drug sales. This research also provides insights into Type 1 Diabetes epidemiology ... Read More
-
Pancreatic Beta-Cell Protection - Hot Targets & Pipeline Analysis
... protection in both Type-1 diabetes & Type-2 diabetes disease progression. This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze ... Read More
-
Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021 Industry Overview
... all over the world and is projected to impact another 592 million by 2035. 29.1 million Americans that is 9.3% of the population have diabetes of both types and close to 2.5 million Americans presently ... Read More
-
Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021 Market Analysis
... databases, company websites, press releases & published research reports are also used for estimates. INSULIN DELIVERY DEVICES – GLOBAL Global market for Insulin Delivery Devices is projected to reach US$16.8 billion by 2021, recording a ... Read More
-
Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021 Report Focus
... disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research ... Read More
-
Global Diabetic Footwear Market Outlook 2021
... or lack of sensation in any part of his body, particularly in his feet. Diabetic/therapeutic shoes have evolved as a medical revolution as it aids in preventing the feet of a diabetic person from developing ... Read More
-
US Blood Glucose Monitoring Systems Market Report
... report include: Traditional Glucose Monitoring Continuous Glucose Monitoring (CGM) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights ... Read More
-
Type 2 Diabetes (T2D) - Pipeline Analysis
... in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies, Gene therapies, Recombinant proteins and RNA-based therapeutics, but excludes ... Read More
-
Sectoral Capsule-Anti Diabetic Drugs Market in India (2009 - 2018)
... a CAGR of 11.30 percent from 2013 to2018. Rise in obese and geriatric population, innovation of new drugs, rapid market adoption ofdrugs and rising income are driving the growth of the market. Due to changes ... Read More
Research Assistance
